search
Back to results

Unnecessary IV Antibiotic Days Using General Criteria for Antibiotic Switch

Primary Purpose

Infection

Status
Completed
Phase
Locations
Norway
Study Type
Observational
Intervention
Implementation of antibiotic switch guidelines
Sponsored by
Sorlandet Hospital HF
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an observational trial for Infection focused on measuring Lower respiratory infection, Upper respiratory infection, Urinary tract infection, Soft tissue infection, Hepatobiliary infection

Eligibility Criteria

15 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Alle patients with suspected infection and who is gives intravenous antibiotics

Exclusion Criteria:

  • CNS-infection
  • Endocarditis
  • Bone/joint infection
  • Undrained abscess
  • Foreign body infection
  • Compromized oral route
  • Immunosuppression
  • Patients meeting the systemic inflammatory response syndrome criteria
  • No preferred oral antibiotic available
  • Other conditions requiring intravenous administration

Sites / Locations

  • Sorlandet Sykehus Arendal
  • Sørlandet Sykehus Kristiansand

Arms of the Study

Arm 1

Arm 2

Arm Type

Arm Label

1

2

Arm Description

Observation group

Intervention group

Outcomes

Primary Outcome Measures

Reduction in the amount of intravenous antibiotic days

Secondary Outcome Measures

Hospital stay duration, re-admittance, re-prescription of intravenous antibiotic therapy

Full Information

First Posted
August 16, 2007
Last Updated
September 29, 2008
Sponsor
Sorlandet Hospital HF
search

1. Study Identification

Unique Protocol Identification Number
NCT00763373
Brief Title
Unnecessary IV Antibiotic Days Using General Criteria for Antibiotic Switch
Official Title
Unnecessary IV Antibiotic Days Using General Criteria for Antibiotic Switch
Study Type
Observational

2. Study Status

Record Verification Date
September 2008
Overall Recruitment Status
Completed
Study Start Date
November 2006 (undefined)
Primary Completion Date
January 2007 (Actual)
Study Completion Date
March 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Sorlandet Hospital HF

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Observation of the use of intravenous antibiotics in medical clinic of Sorlandet Hospital, Norway. Suggestions of criteria for the switch from intravenous to oral administration of antibiotics. Implementation of the criteria and new registration of the use of intravenous antibiotics. Comparison of the amount of the iv-administration before and after the intervention.
Detailed Description
The study is a comparison of the use of intravenous antibiotics before and after the implementation of switch criteria. Switch is defined as a change in administration route from intravenous to oral. Patients administered to medical department at Sorlandet hospital in Kristiansand and Arendal are included if they are receiving intravenous antibiotics. Pediatric department is not included. Patients that are already hospitalized and given intravenous antibiotics are also included. Patients that are excluded are those with CNS-infection, endocarditis, bone/joint infection, deep undrainable abscesses and those with foreign body infection. Switch criteria are made from a thorough investigation on earlier switch studies. We have collected several studies on this topic, but none from the nordic countries. The intervention contributes the following: The implementation of a registration form where doctors are prone to answer six questions when they evaluate antibiotic administration form. Are there special iv-indications? (CNS-infection, endocarditis, bone/joint infection, deep undrainable abscesses or foreign body infection) Is the oral route compromized? (unconscious, nausea, vomiting, diarrhoea, dysphagia, lack of cooperativeness) Is the patients suffering from immunosuppression? (leukopenia, cytotoxic treatment, transplantation, steroids >10mg, TNF-alfa inhibitor treatment, unregulated diabetes mellitus (HbA1C >10), uremia (serum-creatinine > 300), HIV, AIDS, lymphoma, multiple myelomas, cystic fibrosis, asplenic) Is the systemic inflammatory response syndrome present? Is the preferred antibiotics only available in intravenous form? Are there any other special reasons for intravenous antibiotics? If the doctor can answer NO to all these questions, then the patient is a candidate for antibiotic switch from day three after hospitalization. This evaluation form follows the other medical registration forms from day to day. The intervention also includes A lecture by the study group to all our medical doctors. Information by e-mail to all our medical doctors Information by letters to all our medical doctors and chief nurses Registration of parameters used for evaluating antibiotic switch is done three times a week by the study group. We register date and patient information, if other medication is taken orally, heart rate, respiratory rate, temperature, biochemical parameters (CRP and leukocytes), diagnosis and antibiotic choice.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infection
Keywords
Lower respiratory infection, Upper respiratory infection, Urinary tract infection, Soft tissue infection, Hepatobiliary infection

7. Study Design

Enrollment
187 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Description
Observation group
Arm Title
2
Arm Description
Intervention group
Intervention Type
Other
Intervention Name(s)
Implementation of antibiotic switch guidelines
Other Intervention Name(s)
Antibiotic switch
Intervention Description
Implementation of antibiotic switch guidelines
Primary Outcome Measure Information:
Title
Reduction in the amount of intravenous antibiotic days
Time Frame
During stay
Secondary Outcome Measure Information:
Title
Hospital stay duration, re-admittance, re-prescription of intravenous antibiotic therapy
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Alle patients with suspected infection and who is gives intravenous antibiotics Exclusion Criteria: CNS-infection Endocarditis Bone/joint infection Undrained abscess Foreign body infection Compromized oral route Immunosuppression Patients meeting the systemic inflammatory response syndrome criteria No preferred oral antibiotic available Other conditions requiring intravenous administration
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bjoern Waagsboe, Ass dr
Organizational Affiliation
Medical department Kristiansand
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Anders Sundoy, Chief Doc
Organizational Affiliation
Medical dep kristiansand
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Else Quist Paulsen, ass doc
Organizational Affiliation
Med dep Arendal
Official's Role
Study Director
Facility Information:
Facility Name
Sorlandet Sykehus Arendal
City
Arendal
State/Province
Aust-Agder
ZIP/Postal Code
4500
Country
Norway
Facility Name
Sørlandet Sykehus Kristiansand
City
Kristiansand
State/Province
Vest Agder
ZIP/Postal Code
4604
Country
Norway

12. IPD Sharing Statement

Learn more about this trial

Unnecessary IV Antibiotic Days Using General Criteria for Antibiotic Switch

We'll reach out to this number within 24 hrs